Gastroenterology CME

Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Personalizing and Prolonging Care in GIST: Expert Guidance on Integrating New TKI Strategies
Margaret von Mehren, MD
December 8, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Unraveling the Intricacies of HCC Management With Your Multidisciplinary Team: A Closer Look at Effective Selection and Sequencing Strategies in an Expanding Treatment Landscape
Amit Singal, MD, MS
December 1, 2020
Credits: 1.00 CME
PeerView Institute
Preparing for the Next Leap Forward in Multimodal Management of Esophageal/GEJ Cancer: An Interdisciplinary Tumor Board on Adjuvant Immunotherapy
Ronan J. Kelly, MD, MBA
November 11, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Optimizing Precision Medicine in Gastric Cancer Care: Latest and Emerging Evidence on Novel HER2 and Other Molecular-Directed Therapies in Gastric Cancer Management
Josep Tabernero, MD, PhD
October 5, 2020
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Making Headway Toward Better Outcomes in Pancreatic Cancer: The Oncology Nurse as a Leader and Advocate for Patients in an Era of Advances in Care and Research
Gayle Jameson, RN, MSN, ACNP-BC, AOCN
September 22, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Toward Expanded Precision Treatment of HER2- or HER3-Driven Breast, Gastrointestinal, Lung, and Other Cancers: Current Challenges, Opportunities for Improvement, and Practical Considerations
Erika Hamilton, MD
August 6, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Optimizing Precision Medicine in Gastric Cancer Care: Essential Guidance on Translating Scientific Advances With Novel HER2-Targeted Therapies and Other Agents Into Current Clinical Practice
Josep Tabernero, MD, PhD
July 27, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Teaming Up to Improve Liver Cancer Outcomes Through Locoregional and Systemic Therapeutic Strategies: A Multidisciplinary Tumor Board Guiding Optimal Care for Patients Along the Intermediate to Advanced Disease Continuum
Matthew S. Johnson, MD, FSIR
July 22, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Patient Stories From the HCC CaseBook: Expert Guidance on Optimizing Outcomes and Care With Newly Available and Emerging Therapies
Richard S. Finn, MD
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Up Close and Personalizing Gastric Cancer Care: Precision Medicine With HER2-Targeted Therapies and Other Novel Agents
David H. Ilson, MD, PhD
July 8, 2020
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Unlocking the Benefits of Synergy Between Therapeutic Advances and Holistic Care in Gastric/GEJ Cancers: Current Evidence, Practical Guidance, and Point-of-Care Tools for Implementing a Multidisciplinary Approach to Modern Patient Care
Manish A. Shah, MD
June 26, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: HER2-Targeted and Other Agents for Gastric Cancer
David H. Ilson, MD, PhD
June 17, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair’s Take: Review of the Latest HCC Therapy Advancements
Richard S. Finn, MD
June 12, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency
Robin Lachmann, MD, PhD / Melissa Wasserstein, MD
June 3, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Evidence and Practicalities: Checkpoint Inhibition in Gastrointestinal Cancers—Translating Recent Advances in Gastric, Esophageal, and Colorectal Cancers
Manish A. Shah, MD
March 9, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Developing a Therapeutic Game Plan for the Management of Hepatocellular Carcinoma: Expert Insights From the Patient CaseBook
Richard S. Finn, MD
March 6, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat—Personal Insights on Current Practices and Evolving Standards of Care in Pancreatic Cancer: Expert Perspectives on Implementing State-of-the-Art Care in the Clinic
Johanna C. Bendell, MD
March 5, 2020
Credits: 1.50 CME
American Gastroenterological Association
Transforming the Management of Inflammatory Bowel Disease: A Closer Look at the Role of JAK Inhibitors and the Patient’s Perspective in Achieving Therapeutic Goals
David T. Rubin, MD
March 3, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Navigating Diagnosis and Examining the Data: The Clinical Potential of Novel Therapeutic Strategies to Improve Nonalcoholic Steatohepatitis Outcomes
Rohit Loomba, MD, MHSc
March 2, 2020
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Blazing the Therapeutic Management Trail of Biliary Cancers: Get Prepared for a New Era of Molecular- and Mutation-Driven Treatments
Milind Javle, MD
February 25, 2020
Medical Learning Institute, Inc.
The Expanding Playbook of Hepatocellular Carcinoma: Examining Scientific Data and Evidence With Your Multidisciplinary Team
Richard S. Finn, MD
January 13, 2020
Medical Learning Institute, Inc.
HCV 20 x 20: A Screening Initiative to Increase Hepatitis C Testing, Diagnosis, and Linkage to Care in High-Risk Populations
Stacey B. Trooskin, MD, PhD
December 31, 2019
Medical Learning Institute, Inc.
Enhancing Standards of Care for Patients With Biliary Tract Cancers: A Graphical Guide to Integrating a New Lineup of Targeted Therapies Into Practice
Milind Javle, MD
December 27, 2019
Medical Learning Institute, Inc.
MasterClass & Tumor Board⁠—Joining Forces in Hepatocellular Carcinoma: Enhancing Multidisciplinary Care in an Era of New Therapeutic Solutions
Amit Singal, MD, MS
December 24, 2019
Medical Learning Institute, Inc.
Composing Personalized HCC Treatment Strategies: Insights on Harmonizing Patient Care With a Multidisciplinary Ensemble
Ghassan Abou-Alfa, MD, MBA
November 4, 2019